Evidence Report
Midwest CEPAC

PDF cover

MS: Evidence Report

Evidence report on siponimod for secondary progressive MS. This report will serve as the basis for discussion during a public meeting of the Midwest CEPAC in May 2019.

View

View All Materials on this Topic or Go Back to View More Materials